• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.微小 RNA-210 在低氧心肌细胞中通过 Akt 和 p53 依赖性途径上调,并发挥细胞保护作用。
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30. doi: 10.1152/ajpheart.01080.2010. Epub 2011 Aug 12.
2
Inducible miR-145 expression by HIF-1a protects cardiomyocytes against apoptosis via regulating SGK1 in simulated myocardial infarction hypoxic microenvironment.在模拟心肌梗死缺氧微环境中,缺氧诱导因子-1α(HIF-1α)诱导的miR-145表达通过调控血清和糖皮质激素诱导激酶1(SGK1)保护心肌细胞免受凋亡。
Cardiol J. 2018;25(2):268-278. doi: 10.5603/CJ.a2017.0105. Epub 2017 Oct 5.
3
Over-expression of microRNA-494 up-regulates hypoxia-inducible factor-1 alpha expression via PI3K/Akt pathway and protects against hypoxia-induced apoptosis.过表达 microRNA-494 通过 PI3K/Akt 通路上调低氧诱导因子-1α 的表达并抵抗低氧诱导的细胞凋亡。
J Biomed Sci. 2013 Dec 23;20(1):100. doi: 10.1186/1423-0127-20-100.
4
The role of miR-711 in cardiac cells in response to oxidative stress and its biogenesis: a study on H9C2 cells.miR-711 在心脏细胞应对氧化应激及其生物发生中的作用:一项关于 H9C2 细胞的研究。
Cell Mol Biol Lett. 2020 Apr 9;25:26. doi: 10.1186/s11658-020-00206-z. eCollection 2020.
5
HIF-1 regulation of miR-29c impairs SERCA2 expression and cardiac contractility.低氧诱导因子-1 对 miR-29c 的调控作用可损害肌浆网钙泵 2 的表达和心脏收缩力。
Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H554-H565. doi: 10.1152/ajpheart.00617.2018. Epub 2018 Dec 21.
6
Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis.没食子酸表没食子儿茶素酯通过调控 miR-30a/p53 轴防止线粒体损伤和细胞凋亡。
Phytomedicine. 2019 Aug;61:152845. doi: 10.1016/j.phymed.2019.152845. Epub 2019 Jan 30.
7
Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.同源结构域相互作用蛋白激酶-2对HIF-1α活性的抑制与化疗耐药细胞凋亡敏感性相关。
Mol Cancer. 2009 Jan 7;8:1. doi: 10.1186/1476-4598-8-1.
8
MicroRNA-148b-3p is involved in regulating hypoxia/reoxygenation-induced injury of cardiomyocytes in vitro through modulating SIRT7/p53 signaling.microRNA-148b-3p 通过调节 SIRT7/p53 信号通路参与调控体外缺氧/复氧诱导的心肌细胞损伤。
Chem Biol Interact. 2018 Dec 25;296:211-219. doi: 10.1016/j.cbi.2018.10.003. Epub 2018 Oct 9.
9
A feedback regulatory loop between HIF-1α and miR-21 in response to hypoxia in cardiomyocytes.心肌细胞中缺氧时HIF-1α与miR-21之间的反馈调节环。
FEBS Lett. 2014 Aug 25;588(17):3137-46. doi: 10.1016/j.febslet.2014.05.067. Epub 2014 Jun 28.
10
An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p.AKT 和β-肾上腺素能信号通路通过对 miR-199a-5p 的相互作用介导的拮抗作用。
Cell Signal. 2010 Jul;22(7):1054-62. doi: 10.1016/j.cellsig.2010.02.008. Epub 2010 Mar 1.

引用本文的文献

1
Therapeutic potential of apoptotic vesicles in modulating inflammation, immune responses, and tissue regeneration.凋亡小泡在调节炎症、免疫反应和组织再生方面的治疗潜力。
J Nanobiotechnology. 2025 Apr 1;23(1):260. doi: 10.1186/s12951-025-03278-1.
2
miR-1233-3p Inhibits Angiopoietin-1-Induced Endothelial Cell Survival, Migration, and Differentiation.微小RNA-1233-3p抑制血管生成素-1诱导的内皮细胞存活、迁移和分化。
Cells. 2025 Jan 8;14(2):75. doi: 10.3390/cells14020075.
3
The Role of Circulating MicroRNAs in Cardiovascular Diseases: A Novel Biomarker for Diagnosis and Potential Therapeutic Targets?循环微RNA在心血管疾病中的作用:一种用于诊断的新型生物标志物及潜在治疗靶点?
Cureus. 2024 Jul 8;16(7):e64100. doi: 10.7759/cureus.64100. eCollection 2024 Jul.
4
Hypoxia-preconditioned WJ-MSC spheroid-derived exosomes delivering miR-210 for renal cell restoration in hypoxia-reoxygenation injury.缺氧预适应 WJ-MSC 球状体来源的外泌体递送 miR-210 用于缺氧再复氧损伤中的肾细胞修复。
Stem Cell Res Ther. 2024 Jul 30;15(1):240. doi: 10.1186/s13287-024-03845-7.
5
miR-210-5p Promotes Pulmonary Hypertension by Blocking ATP2A2.微小RNA-210-5p通过阻断ATP2A2促进肺动脉高压。
Cardiovasc Drugs Ther. 2024 Apr 24. doi: 10.1007/s10557-024-07568-y.
6
Exercise-Induced miR-210 Promotes Cardiomyocyte Proliferation and Survival and Mediates Exercise-Induced Cardiac Protection against Ischemia/Reperfusion Injury.运动诱导的miR-210促进心肌细胞增殖与存活,并介导运动诱导的心脏对缺血/再灌注损伤的保护作用。
Research (Wash D C). 2024 Feb 26;7:0327. doi: 10.34133/research.0327. eCollection 2024.
7
Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer.缺氧诱导的miR-210对胰腺癌的影响
Curr Issues Mol Biol. 2023 Dec 5;45(12):9778-9792. doi: 10.3390/cimb45120611.
8
The miR-210 Primed Endothelial Progenitor Cell Exosomes Alleviate Acute Ischemic Brain Injury.miR-210预激活的内皮祖细胞外泌体减轻急性缺血性脑损伤。
Curr Stem Cell Res Ther. 2024;19(8):1164-1174. doi: 10.2174/011574888X266357230923113642.
9
The roles of miRNAs in adult skeletal muscle satellite cells.miRNAs 在成年骨骼肌卫星细胞中的作用。
Free Radic Biol Med. 2023 Nov 20;209(Pt 2):228-238. doi: 10.1016/j.freeradbiomed.2023.10.403. Epub 2023 Oct 24.
10
HypoxamiR-210-3p regulates mesenchymal stem cells proliferation via P53 & Akt.缺氧 miR-210-3p 通过 P53 和 Akt 调节间充质干细胞增殖。
Mol Cell Biochem. 2024 Aug;479(8):2119-2129. doi: 10.1007/s11010-023-04834-9. Epub 2023 Aug 24.

本文引用的文献

1
Role of microRNAs in cardiac remodeling and heart failure.微小 RNA 在心脏重构和心力衰竭中的作用。
Cardiovasc Drugs Ther. 2011 Apr;25(2):171-82. doi: 10.1007/s10557-011-6289-5.
2
MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).微小 RNA-210 通过靶向成纤维细胞生长因子受体样 1(FGFRL1)调节癌细胞增殖。
J Biol Chem. 2011 Jan 7;286(1):420-8. doi: 10.1074/jbc.M110.170852. Epub 2010 Nov 2.
3
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.miR-210 在肺癌晚期过表达,并介导与 HIF-1 活性调节相关的线粒体改变。
Cell Death Differ. 2011 Mar;18(3):465-78. doi: 10.1038/cdd.2010.119. Epub 2010 Oct 1.
4
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease.miR-210 作为一种治疗缺血性心脏病的新疗法。
Circulation. 2010 Sep 14;122(11 Suppl):S124-31. doi: 10.1161/CIRCULATIONAHA.109.928424.
5
miRNAs as therapeutic targets in ischemic heart disease.miRNAs 作为缺血性心脏病的治疗靶点。
J Cardiovasc Transl Res. 2010 Jun;3(3):280-9. doi: 10.1007/s12265-010-9173-y. Epub 2010 Mar 30.
6
Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression.缺氧调节 microRNA-210 调节线粒体功能并降低 ISCU 和 COX10 的表达。
Oncogene. 2010 Jul 29;29(30):4362-8. doi: 10.1038/onc.2010.193. Epub 2010 May 24.
7
MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU.MicroRNA-210 通过靶向铁硫簇蛋白 ISCU 调节癌细胞对缺氧和克雷布斯循环的线粒体自由基反应。
PLoS One. 2010 Apr 26;5(4):e10345. doi: 10.1371/journal.pone.0010345.
8
MicroRNAs in angiogenesis and vascular smooth muscle cell function.微小RNA在血管生成及血管平滑肌细胞功能中的作用
Circ Res. 2010 Feb 19;106(3):423-5. doi: 10.1161/RES.0b013e3181d61a0d.
9
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.MicroRNA-210 通过抑制铁硫簇装配蛋白 ISCU1/2 来控制低氧条件下的线粒体代谢。
Cell Metab. 2009 Oct;10(4):273-84. doi: 10.1016/j.cmet.2009.08.015.
10
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.缺氧诱导的mir-210调节参与肿瘤起始的常氧基因表达。
Mol Cell. 2009 Sep 24;35(6):856-67. doi: 10.1016/j.molcel.2009.09.006.

微小 RNA-210 在低氧心肌细胞中通过 Akt 和 p53 依赖性途径上调,并发挥细胞保护作用。

microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.

机构信息

Feinberg Cardiovascular Research Institute, Northwestern University, Chicago, Illinois 60611, USA.

出版信息

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30. doi: 10.1152/ajpheart.01080.2010. Epub 2011 Aug 12.

DOI:10.1152/ajpheart.01080.2010
PMID:21841015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3197368/
Abstract

microRNA-210 (miR-210) is upregulated in hypoxia, but its function in cardiomyocytes and its regulation in response to hypoxia are not well characterized. The purpose of this study was to identify upstream regulators of miR-210, as well as to characterize miR-210's function in cardiomyocytes. We first showed miR-210 is upregulated through both hypoxia-inducible factor (HIF)-dependent and -independent pathways, since aryl hydrocarbon nuclear translocator (ARNT) knockout mouse embryonic fibroblasts (MEF), lacking intact HIF signaling, still displayed increased miR-210 levels in hypoxia. To determine the mechanism for HIF-independent regulation of miR-210, we focused on p53 and protein kinase B (Akt). Overexpression of p53 in wild-type MEFs induced miR-210, whereas p53 overexpression in ARNT knockout MEFs did not, suggesting p53 regulates miR-210 in a HIF-dependent mechanism. Akt inhibition reduced miR-210 induction by hypoxia, whereas Akt overexpression increased miR-210 levels in both wild-type and ARNT knockout MEFs, indicating Akt regulation of miR-210 is HIF-independent. We then studied the effects of miR-210 in cardiomyocytes. Overexpression of miR-210 reduced cell death in response to oxidative stress and reduced reactive oxygen species (ROS) production both at baseline and after treatment with antimycin A. Furthermore, downregulation of miR-210 increased ROS after hypoxia-reoxygenation. To determine a mechanism for the cytoprotective effects of miR-210, we focused on the predicted target, apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3), known to induce cell death. Although miR-210 reduced AIFM3 levels, overexpression of AIFM3 in the presence of miR-210 overexpression did not reduce cellular viability either at baseline or after hydrogen peroxide treatment, suggesting AIFM3 does not mediate miR-210's cytoprotective effects. Furthermore, HIF-3α, a negative regulator of HIF signaling, is targeted by miR-210, but miR-210 does not modulate HIF activity. In conclusion, we demonstrate a novel role for p53 and Akt in regulating miR-210 and demonstrate that, in cardiomyocytes, miR-210 exerts cytoprotective effects, potentially by reducing mitochondrial ROS production.

摘要

miR-210(miR-210)在低氧条件下上调,但它在心肌细胞中的功能及其对低氧的反应尚未得到很好的描述。本研究的目的是鉴定 miR-210 的上游调控因子,并研究 miR-210 在心肌细胞中的功能。我们首先表明,miR-210 通过缺氧诱导因子(HIF)依赖性和非依赖性途径上调,因为芳香烃核转位蛋白(ARNT)敲除的小鼠胚胎成纤维细胞(MEF)缺乏完整的 HIF 信号通路,但其在低氧条件下仍显示出 miR-210 水平的增加。为了确定 miR-210 非 HIF 依赖性调节的机制,我们集中研究了 p53 和蛋白激酶 B(Akt)。在野生型 MEF 中转染 p53 可诱导 miR-210,而在 ARNT 敲除 MEF 中转染 p53 则不能,表明 p53 通过 HIF 依赖性机制调节 miR-210。Akt 抑制可降低低氧诱导的 miR-210 诱导,而 Akt 过表达可增加野生型和 ARNT 敲除 MEF 中的 miR-210 水平,表明 Akt 对 miR-210 的调节是不依赖 HIF 的。然后,我们研究了 miR-210 在心肌细胞中的作用。miR-210 的过表达可降低氧化应激引起的细胞死亡,并降低基础水平和抗霉素 A 处理后的活性氧(ROS)产生。此外,低氧复氧后 miR-210 的下调会增加 ROS。为了确定 miR-210 细胞保护作用的机制,我们集中研究了预测的靶标,凋亡诱导因子,线粒体相关 3(AIFM3),已知其可诱导细胞死亡。尽管 miR-210 降低了 AIFM3 的水平,但在 miR-210 过表达的情况下过表达 AIFM3,无论是在基础水平还是在过氧化氢处理后,细胞活力均未降低,这表明 AIFM3 并不介导 miR-210 的细胞保护作用。此外,HIF-3α,HIF 信号的负调节剂,是 miR-210 的靶标,但 miR-210 不调节 HIF 活性。总之,我们证明了 p53 和 Akt 在调节 miR-210 方面具有新的作用,并证明在心肌细胞中,miR-210 发挥细胞保护作用,可能通过减少线粒体 ROS 的产生。